About Anthony Meehan
Form D filings for Venatorx Pharmaceuticals from 2017 to 2023 list Anthony Meehan as executive officer.
Anthony Meehan first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Anthony Meehan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Anthony Meehan works with at each company, as listed on that company's latest Form D.
Venatorx Pharmaceuticals, Inc. · Form D/A, Jul 13, 2023
TH
Timothy Haines
Director
TH
Tomas Heyman
Director
CB
Christopher Burns
President and director
DP
Daniel Pevear
Executive officer
SP
Sergei Petukhov
Director
MH
Martin Heidecker
Director